Search Results 1281-1290 of 14766 for anti-TNF drugs

1. Efavirenz, Emtricitabine, And Tenofovir (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

2. Isocarboxazid (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

3. Aldesleukin (Intravenous Route) Proper Use - Mayo Clinic

   Medicines used to treat cancer are very strong and can have many side effects. Before receiving this medicine, make sure you understand all the risks and ...

4. Terbinafine (Topical Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. LamISIL; LamISIL AT. Canadian Brand Name.

5. Ciprofloxacin (Intratympanic Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

6. Nisoldipine (Oral Route) Description and Brand Names - Mayo Clinic

   Nisoldipine is used alone or together with other medicines to treat high blood pressure. High blood pressure adds to the workload of the heart and arteries. If ...

7. Phentolamine (Ophthalmic Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

8. Fluticasone And Vilanterol (Inhalation Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

9. A Study to Evaluate the Safety, Effectiveness and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment - Mayo Clinic

   To evaluate a new oral treatment, ABI-M201 (or placebo) in individuals with mild to moderate Ulcerative Colitis who have sustained an inadequate response to ...

10. Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis - Mayo Clinic

    By condition, treatment or drug name. Search ... - Belimumab, telitacicept, abatacept, TNF-? mAb ... anti-TB treatment, participants with history of ...